The FDA evaluated a product's public health risk after it failed to prove public health benefit.
1 report, 1 independent
Updated Aug 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA evaluated a product's public health risk after it failed to prove public health benefit.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Food and Drug Administration
government organization in Nonthaburi, Thailand
-
Blu
Italian artist
Nothing else this week.
Related events
- The 21st Century Cures Act granted the Food and Drug Administration increased flexibility in the required proof for regulatory actions.
- FDA recalls are leading to a significant loss of consumer confidence regarding products from an American company.
- DoMS findings informed regulatory actions taken by the Food and Drug Administration.
- FDA issued a safety alert regarding device failure involving Medtronic and Given Imaging.
- The Food and Drug Administration mandated inventory and destruction of expired food products involving Amazon.
Coverage
Newest first; wire copies grouped- C-Store DiveFDA denies marketing for Blu vape This story was originally published on C-Store Dive. To receive daily news and insights, subscribe to our free daily C-Store Dive newsletter. The Food and Drug Admi